CL
Charter Life Sciences
Micro VCActiveCharter Life Sciences is a clinical-stage venture capital firm focused on investments in early-stage opportunities.
22
Investments
5
Exits
—
AUM
22.7%
Exit Rate
Get contact info, warm intros & fit scores
Sign up to unlock emails, Signal intro paths, and personalized fit analysis for Charter Life Sciences.
Investment Thesis & Strategy
Charter Life Sciences invests in early-stage biotech and life science companies, specifically focusing on clinical-stage opportunities.
Investment Activity
Deals per year over the last 7 years
1
20150
20160
20170
20180
20195
20206
2021Portfolio Companies
Selected investments from their portfolio of 22 companies
V
Vaxxinity
Biotech · Series B, 2021
I
Immatics
Biotech · Growth, 2021
T
TScan Therapeutics
Biotech · Series B, 2021
C
Cellares
Biotech · Series B, 2021
I
Instil Bio
Biotech · Series B, 2021
L
Lyell Immunopharma
Biotech · Series B, 2021
S
Sana Biotechnology
Biotech · Series B, 2020
O
Obsidian Therapeutics
Biotech · Series B, 2020
T
Triumvira Immunologics
Biotech · Series A, 2020
V
Vor Biopharma
Biotech · Series B, 2020
C
Century Therapeutics
Biotech · Series B, 2020
K
Kura Oncology
Biotech · Series A, 2015
Frequently Asked Questions
Charter Life Sciences focuses on Seed, Series A stage investments.
Related Investors
Oriza Ventures
Santa Clara, United States · 38 deals
Acorn Pacific Ventures
Santa Clara, United States · 19 deals
Entrepia Ventures
Santa Clara, United States · 17 deals
Heuristic Capital
Santa Clara, United States · 13 deals
SV Angel
San Francisco, United States · 922 deals
Right Side Capital Management
San Francisco, United States · 894 deals